Plunkett Research Online: Biotie Therapies Oyj

BIOTIE THERAPIES OYJ (BIOZF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Biotie Therapies Corp is a Finland based biopharmaceutical company engaged in developing and marketing therapies that restore function and improve the lives of people with neurological disorders in Finland and the United States. Its product portfolio includes CVT-301, CVT-427, SYN120, rHIgM22 and BT.....



Biotie Therapies Oyj
Ticker: BIOZF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 358 22748900
Fax: 358 22748910
Address: Joukahaisenkatu 6
Turku, 20520 Finland

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
David CookCFO
William BurnsChairman of the Board/Director
See More
Biotie Therapies Corp is a Finland based biopharmaceutical company engaged in developing and marketing therapies that restore function and improve the lives of people with neurological disorders in Finland and the United States. Its product portfolio includes CVT-301, CVT-427, SYN120, rHIgM22 and BT.....See More See More

Auditor: PricewaterhouseCoopers
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201520142013201220112010
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: